Literature DB >> 6606218

T-cell growth factor contains activity that supports natural killer activity in vitro.

K O Grönvik, J Andersson, G Alm, P Stern.   

Abstract

Lymphocytes from athymic and normal mice were tested and compared for cytotoxic activity after in vitro cultures supplemented with concanavalin A or T-cell growth factor (TCGF). Our results indicate that, in addition to cytotoxic T cells, natural killer (NK) activity can be recovered from lymphocytes cultured in the presence of TCGF and that this is not the result of contaminating interferon in the TCGF preparations. The NK nature of the effector cells was established by means of a panel of target cells, including a teratocarcinoma tumour cell, which enabled the distinction of T-cell- and NK-cell-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606218     DOI: 10.1111/j.1365-3083.1983.tb01802.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

Review 1.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

2.  Tumour inhibitory effects of TCGF/IL-2/-containing preparations.

Authors:  J Bubeník; M Indrová; P Perlmann; K Berzins; O Mach; J Kraml; A Toulcová
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells.

Authors:  Y Fujimiya; W C Chang; A Bakke; D Horwitz; P K Pattengale
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Enrichment of rat NK cytotoxicity for H2-negative murine embryonal carcinoma cells by panning and short-term culture in TCGF.

Authors:  S M Bell; R Aspinall; P L Stern
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.